BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 23067538)

  • 1. 18F-Misonidazole PET-CT scan detection of occult bone metastasis.
    McGowan DR; Macpherson RE; Bradley KM; Fenwick JD; Gleeson FV; Higgins GS
    Thorax; 2016 Jan; 71(1):97. PubMed ID: 26349764
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent Metastatic Ewing Sarcoma Involving Only in the Muscles of Extremities Shown on FDG PET/CT.
    Fleury AS; Zhuang H
    Clin Nucl Med; 2024 Jun; 49(6):589-591. PubMed ID: 38537215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT in oncology.
    Fahim-Ul-Hassan ; Cook GJ
    Clin Med (Lond); 2012 Aug; 12(4):368-72. PubMed ID: 22930885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of bone metastasis in non-small cell lung cancer].
    Apeiranthiti A; Vanniere F; Bayoumy K; Christofis M; Serena A; Mosimann V; Abdelhamid K; Papadopoulos S; Nguyen-Ngoc T; Bouchaab H; Peters S; Mederos N
    Rev Med Suisse; 2024 May; 20(874):973-977. PubMed ID: 38756034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional imaging biomarkers for assessing response to treatment in liver and lung metastases.
    Bernardin L; O'Flynn EA; Desouza NM
    Cancer Imaging; 2013 Dec; 13(4):482-94. PubMed ID: 24334562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features, Treatments, and Prognosis of Intramedullary Spinal Cord Metastases From Lung Cancer: A Case Series and Systematic Review.
    Wu L; Wang L; Yang J; Jia W; Xu Y
    Neurospine; 2022 Mar; 19(1):65-76. PubMed ID: 35130420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI.
    Batouli A; Braun J; Singh K; Gholamrezanezhad A; Casagranda BU; Alavi A
    J Neurooncol; 2018 Jun; 138(2):221-230. PubMed ID: 29484521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
    Miele E; Spinelli GP; Tomao F; Zullo A; De Marinis F; Pasciuti G; Rossi L; Zoratto F; Tomao S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):52. PubMed ID: 18928537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramedullary metastasis detected with 18F FDG-PET/CT.
    Sari O; Kaya B; Kara Gedik G; Ozcan Kara P; Varoglu E
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):299-300. PubMed ID: 23067538
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple distant muscular metastases from non-small cell lung carcinoma evidenced by 18F-FDG PET/CT.
    Caobelli F; Pizzocaro C; Guerra UP
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):338-9. PubMed ID: 23809515
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramedullary spinal cord metastasis.
    Pellegrini D; Quezel MA; Bruetman JE
    Arch Neurol; 2009 Nov; 66(11):1422. PubMed ID: 19901180
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
    Liu SW; Yu JM; Xing LG
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):626-9. PubMed ID: 15634527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular metastases on FDG PET-CT: a review of the literature.
    Emmering J; Vogel WV; Stokkel MP
    Nucl Med Commun; 2012 Feb; 33(2):117-20. PubMed ID: 22124361
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.